Fortrea Holdings Inc. FTRE
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2023-06-16
Fortrea Holdings Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating margin | -32.0% | -6.0% | 1.1% | 6.6% |
| Net margin | -36.2% | -12.2% | -0.9% | 6.6% |
| Return on assets | -36.3% | -9.2% | -0.6% | 4.3% |
| Return on equity | -175.0% | -24.1% | -1.5% | 5.6% |
| Debt / equity | 1.86× | 0.77× | 0.91× | 0.00× |
| Current ratio | 0.98 | 1.00 | 1.61 | 1.78 |
| Revenue growth | 1.0% | -5.1% | 0.2% | — |
Source: SEC EDGAR filings · CIK 0001965040 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.